JSR Life Sciences LLC, a group company under JSR Corp. (TYO:4185), recently announced that it will be expanding cutting-edge facilities in Europe to grow its business for biopharmaceuticals. These facilities will serve to bolster the activities of two affiliates: namely, U.S.-based KBI Biopharma Inc. and Swiss-based Selexis SA. Through this expansion, the two affiliates will end up occupying a combined...
JSR Corp. (TYO:4185) is working to transfer control of its life sciences business to U.S.-based JSR Life Sciences LLC., a new company established on Jan. 1 under wholly owned subsidiary JSR North America Holdings Inc. Practical operations here are slated to begin on April 1. So far, JSR has grown its life sciences business on a global level, conducting M&A...
Signup today for free.
You will receive a weekly or daily roundup on what has been published and will be up to date on special offers.
Please make sure to select your preferred sending frequency!
Note: We save your entered data to send the newsletter. You can always easily unsubscribe. More information on data handling: Privacy Policy.
Close window
